Nebulized Magnesium Sulfate in Children With Moderate to Severe Asthma

Nebulized Magnesium Sulfate in Children With Moderate to Severe Asthma Exacerbation: A Randomized, Double-Blind, Controlled Trial (RCT)

The purpose of this study is to investigate the use of magnesium sulfate nebulization in patient with moderate to severe asthma exacerbation in pediatric emergency.

the use of magnesium sulfate nebulization in patient with moderate to severe asthma exacerbation in pediatric emergency

follow asthma severity score and length of stay

Inclusion Criteria:

• Pediatric asthma patients with moderate to severe exacerbation

Exclusion Criteria:

• Known allergy to magnesium sulfate
• History of neuromuscular disease, cardiac disease, renal disease, or underlying chronic lung disease
• Use of oral steroid medication within 72 hours of presentation
• Radiographic evidence of pneumonia at presentation
• Administration of intravenous magnesium sulfate prior to study enrollment